Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence
Patent
1990-10-16
1994-11-15
Lee, Lester L.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
15 to 23 amino acid residues in defined sequence
530327, 530325, A61K 3702, C07K 706, C07K 708
Patent
active
053649303
ABSTRACT:
The invention provides a fragment of Clq which is characterized in that a plurality of such fragments selectively binds immune complexes or aggregated immunoglobulins in the presence of monomeric immunoglobulin. The invention also provides a synthetic peptide comprising the sequence: ##STR1## or variants thereof capable of binding immunoglobulin. Like the Clq fragment, a plurality of the peptides can selectively bind immune complexes or aggregated immunoglobulins in the presence of monomeric immunoglobulin. As a result of this property, the fragments and peptides are well-adapted for removing immune complexes and aggregated immunoglobulins from fluids containing monomeric immunoglobulin, and for detecting or quantitating immune complexes in such fluids. The invention also provides a binding material for removing immune complexes or aggregated immunoglobulins from a fluid. The binding material comprises plural binding peptides, the peptides being characterized in that a plurality of them selectively binds immune complexes and aggregated immunoglobulins in the presence of monomeric immunoglobulin.
REFERENCES:
patent: 3941763 (1976-03-01), Sarantakis
patent: 4546082 (1985-10-01), Kurjan et al.
patent: 4588684 (1986-05-01), Brake
patent: 4775622 (1988-10-01), Hitzeman et al.
patent: 5084398 (1992-01-01), Huston et al.
Blair, A. H., and Ghose, T. I., J. Immunol. Methods, 59:129-143 (1983).
Burton, Molec. Immunol., 22, 161-206 (1985).
Burton, Molec. Immunol., 25, 1175-81 (1988).
Burton et al., Nature, 288, 338-44 (1980).
Chou and Fasman, Adv. Enzym., 47, 45-148 (1978).
Davis et al., Biochem. Int'l, 10, 395-404 (1985).
DeGrado et al., J. Am. Chem. Soc., 103, 679-81 (1981).
Duncan and Winter, Nature, 332, 738-40 (1988).
Ellman, Arch. Biochem. Biophys., 74, 443-450 (1958).
Ellman, Arch. Biochem. Biophys., 82, 70-77 (1959).
Erickson et al. in the Proteins, 3rd ed., vol. 2, pp. 257-527 (1976).
Fields, Meth. Enzymol., 25B, 464-68 (1972).
Garnier et al., J. Molec. Biol., 120, 97-120 (1978).
Gauthier, et al., J. Exp. Med., 156:776-77 (1982).
Geusdon et al., J. Histochem. Cytochem., 27, 1131-39 (1979).
Hughes-Jones and Gardner, Immunology, 34, 459-63 (1978).
Jones et al., J. Immunol. Meth., 53, 201-208 (1982).
Kulkarni, P. N., Blair, A. H., and Ghose, T. I., Cancer Res., 41:2700-06 (1981).
Lancet et al., Biochem. Biophys. Res. Commun., 85, 608-614 (1978).
Langone et al., Adv. Immunol., 32, 157-252 (1982).
Langone et al., J. Immunol., 121, 327-32 (1978).
Lukas et al., J. Immunol., 127, 2555-60 (1981).
Marquart et al., J. Mol. Biol., 141, 369-91 (1980).
Merrifield, in Chem. Polypeptides, pp. 335-61 (Katsoyannis and Panayotis eds. 1973).
Merrifield, J. Am. Chem. Soc., 85, 2149-54 (1963).
Moe and Kaiser, Biochem., 24, 1971-76 (1985).
Prystowsky et al., Biochemistry, 20, 6349-56 (1981).
Reid, Biochemical J., 179, 367-71 (1979).
Reid, et al., Biochemical J., 203, 559-69 (1982).
Stalinheim et al., Immunochem., 10, 501-507 (1973).
Stewart and Young, Solid Phase Peptide Synthesis (1969).
Taylor et al., Mol. Pharmacol., 22, 657-66 (1982).
Theofilopoulos and Dixon, Adv. Immunol., 28, 89-220 (1979).
Anderson Byron E.
Baumann Michael A.
Lee Lester L.
Northwestern University
LandOfFree
Synthetic C1q peptide fragments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic C1q peptide fragments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic C1q peptide fragments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1098471